Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Bellmann-Strobl

Showing results (41-50 of 173) with videos related to

Pageof 18
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 15, 2021
Longitudinal analysis of T1w/T2w ratio in patients with multiple sclerosis from first clinical presentationGraham Cooper, Claudia Chien, Hanna Zimmermann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 10, 2016
Characterizing the phenotype of multiple sclerosis-associated depression in comparison with idiopathic major depressionHelge Hasselmann, Judith Bellmann-Strobl, Roland Ricken, et al.
Plos One|April 16, 2011
Association of retinal and macular damage with brain atrophy in multiple sclerosisJan Dörr, Klaus D Wernecke, Markus Bock, et al.
Plos One|April 10, 2008
Oral high-dose atorvastatin treatment in relapsing-remitting multiple sclerosisFriedemann Paul, Sonia Waiczies, Jens Wuerfel, et al.
European Journal of Neurology|July 30, 2015
Low 25-hydroxyvitamin D, but not the bioavailable fraction of 25-hydroxyvitamin D, is a risk factor for multiple sclerosisJanina R Behrens, Ludwig Rasche, Rene M Gieß, et al.
Journal of Neuroimmunology|July 12, 2016
Fine specificity of the antibody response to Epstein-Barr nuclear antigen-2 and other Epstein-Barr virus proteins in patients with clinically isolated syndrome: A peptide microarray-based case-control studyLudwig Schlemm, René Markus Giess, Ludwig Rasche, et al.
Brain Communications|September 21, 2020
Imaging markers of disability in aquaporin-4 immunoglobulin G seropositive neuromyelitis optica: a graph theory studyClaudia Chien, Frederike Cosima Oertel, Nadja Siebert, et al.
Frontiers in Neurology|October 26, 2020
Differences in Advanced Magnetic Resonance Imaging in MOG-IgG and AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorders: A Comparative StudyFelix A Schmidt, Claudia Chien, Joseph Kuchling, et al.
Multiple Sclerosis and Related Disorders|January 21, 2017
Severe structural and functional visual system damage leads to profound loss of vision-related quality of life in patients with neuromyelitis optica spectrum disordersFelix Schmidt, Hanna Zimmermann, Janine Mikolajczak, et al.
BMC Neurology|January 15, 2017
Subjective and objective assessment of physical activity in multiple sclerosis and their relation to health-related quality of lifeTheresa Krüger, Janina R Behrens, Anuschka Grobelny, et al.
Pageof 18

Showing results (41-50 of 173) with videos related to

Sort By:
Pageof 18
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 15, 2021
Longitudinal analysis of T1w/T2w ratio in patients with multiple sclerosis from first clinical presentationGraham Cooper, Claudia Chien, Hanna Zimmermann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 10, 2016
Characterizing the phenotype of multiple sclerosis-associated depression in comparison with idiopathic major depressionHelge Hasselmann, Judith Bellmann-Strobl, Roland Ricken, et al.
Plos One|April 16, 2011
Association of retinal and macular damage with brain atrophy in multiple sclerosisJan Dörr, Klaus D Wernecke, Markus Bock, et al.
Plos One|April 10, 2008
Oral high-dose atorvastatin treatment in relapsing-remitting multiple sclerosisFriedemann Paul, Sonia Waiczies, Jens Wuerfel, et al.
European Journal of Neurology|July 30, 2015
Low 25-hydroxyvitamin D, but not the bioavailable fraction of 25-hydroxyvitamin D, is a risk factor for multiple sclerosisJanina R Behrens, Ludwig Rasche, Rene M Gieß, et al.
Journal of Neuroimmunology|July 12, 2016
Fine specificity of the antibody response to Epstein-Barr nuclear antigen-2 and other Epstein-Barr virus proteins in patients with clinically isolated syndrome: A peptide microarray-based case-control studyLudwig Schlemm, René Markus Giess, Ludwig Rasche, et al.
Brain Communications|September 21, 2020
Imaging markers of disability in aquaporin-4 immunoglobulin G seropositive neuromyelitis optica: a graph theory studyClaudia Chien, Frederike Cosima Oertel, Nadja Siebert, et al.
Frontiers in Neurology|October 26, 2020
Differences in Advanced Magnetic Resonance Imaging in MOG-IgG and AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorders: A Comparative StudyFelix A Schmidt, Claudia Chien, Joseph Kuchling, et al.
Multiple Sclerosis and Related Disorders|January 21, 2017
Severe structural and functional visual system damage leads to profound loss of vision-related quality of life in patients with neuromyelitis optica spectrum disordersFelix Schmidt, Hanna Zimmermann, Janine Mikolajczak, et al.
BMC Neurology|January 15, 2017
Subjective and objective assessment of physical activity in multiple sclerosis and their relation to health-related quality of lifeTheresa Krüger, Janina R Behrens, Anuschka Grobelny, et al.
Pageof 18